159 related articles for article (PubMed ID: 35116259)
1. Microarray analysis of miRNA based on the regional lymph node metastasis status of esophageal squamous cell carcinoma.
Xu Y; Sun D; Zhang X; Liu J; Wang J; Cao Q; Wang Y; Hu L
Transl Cancer Res; 2021 Jan; 10(1):273-287. PubMed ID: 35116259
[TBL] [Abstract][Full Text] [Related]
2. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide analysis of long non-coding RNAs in esophageal squamous cell carcinoma reveals their potential role in invasion and metastasis.
Wang J; Sun D; Wu K; Liu J; Zhao M; Li X; Xu Y; Li B
Thorac Cancer; 2019 Jan; 10(1):78-89. PubMed ID: 30390388
[TBL] [Abstract][Full Text] [Related]
4. CT radiomics features to predict lymph node metastasis in advanced esophageal squamous cell carcinoma and to discriminate between regional and non-regional lymph node metastasis: a case control study.
Ou J; Wu L; Li R; Wu CQ; Liu J; Chen TW; Zhang XM; Tang S; Wu YP; Yang LQ; Tan BG; Lu FL
Quant Imaging Med Surg; 2021 Feb; 11(2):628-640. PubMed ID: 33532263
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of microRNA-19a-3p promotes lymph node metastasis of esophageal squamous cell carcinoma via the RAC1/CDC42-PAK1 pathway.
Zhong H; Xu Y; Wang J; Cao Q; Hu L; Sun D
Transl Cancer Res; 2021 Jun; 10(6):2694-2706. PubMed ID: 35116581
[TBL] [Abstract][Full Text] [Related]
6. microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival.
Wei Q; Li X; Yu W; Zhao K; Qin G; Chen H; Gu Y; Ding F; Zhu Z; Fu X; Sun M
J Cell Biochem; 2019 Aug; 120(8):12259-12272. PubMed ID: 31017699
[TBL] [Abstract][Full Text] [Related]
7. Nomogram for prediction of lymph node metastasis in patients with superficial esophageal squamous cell carcinoma.
Min BH; Yang JW; Min YW; Baek SY; Kim S; Kim HK; Choi YS; Shim YM; Choi YL; Zo JI
J Gastroenterol Hepatol; 2020 Jun; 35(6):1009-1015. PubMed ID: 31674067
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
[TBL] [Abstract][Full Text] [Related]
9. Construction and Evaluation of a Risk Score Model for Lymph Node Metastasis-Associated Circadian Clock Genes in Esophageal Squamous Carcinoma.
Cheng J; Chen F; Cheng Y
Cells; 2022 Oct; 11(21):. PubMed ID: 36359828
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis.
Jiang KY; Huang H; Chen WY; Yan HJ; Wei ZT; Wang XW; Li HX; Zheng XY; Tian D
World J Gastroenterol; 2021 Feb; 27(8):737-750. PubMed ID: 33716451
[TBL] [Abstract][Full Text] [Related]
11. Serum miRNA expression in patients with esophageal squamous cell carcinoma.
Hui B; Chen X; Hui L; Xi R; Zhang X
Oncol Lett; 2015 Nov; 10(5):3008-3012. PubMed ID: 26722280
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
[TBL] [Abstract][Full Text] [Related]
13. Predictive microRNAs for lymph node metastasis in endoscopically resectable submucosal colorectal cancer.
Jung CK; Jung SH; Yim SH; Jung JH; Choi HJ; Kang WK; Park SW; Oh ST; Kim JG; Lee SH; Chung YJ
Oncotarget; 2016 May; 7(22):32902-15. PubMed ID: 27096956
[TBL] [Abstract][Full Text] [Related]
14. Implication of clinical target delineation for T1b/T2 thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases.
Guan H; Yu Y; Ge H; Zhu S; Huang W; Li B
Future Oncol; 2019 Oct; 15(29):3345-3355. PubMed ID: 31578872
[No Abstract] [Full Text] [Related]
15. Differential expression profiling of microRNAs and their potential involvement in esophageal squamous cell carcinoma.
Zang W; Wang Y; Du Y; Xuan X; Wang T; Li M; Ma Y; Li P; Chen X; Dong Z; Zhao G
Tumour Biol; 2014 Apr; 35(4):3295-304. PubMed ID: 24272087
[TBL] [Abstract][Full Text] [Related]
16. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
17. Plasma miRNA-506 as a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma.
Li SP; Su HX; Zhao D; Guan QL
Med Sci Monit; 2016 Jun; 22():2195-201. PubMed ID: 27345473
[TBL] [Abstract][Full Text] [Related]
18. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
19. Role of Lower Esophageal Squamous Cell Carcinoma Margin Location on Abdominal Lymph Node Metastasis Risk.
Zhong X; Tu XH; A-Lai GH; Zhuo ZG; Yao P; Zhang Y; Xu ZJ; Lin YD
J Clin Med; 2023 Apr; 12(7):. PubMed ID: 37048740
[TBL] [Abstract][Full Text] [Related]
20. High programmed death-ligand 1 expression is a poor prognostic indicator for esophageal squamous cell carcinoma and is correlated with two-field lymph node metastasis.
Liang M; Yu F; Wu W; Chen H; Zheng B; Zheng W; Zhu Y; Chen C
Transl Cancer Res; 2020 Apr; 9(4):2472-2481. PubMed ID: 35117606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
